Pfizer tests drug interaction in 12 healthy volunteers
NCT ID NCT07636018
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 1 study tested how the antifungal drug fluconazole changes the way the body processes an experimental drug called PF-07248144. Twelve healthy adults took PF-07248144 alone and then again with fluconazole. Researchers measured drug levels in the blood to understand the interaction and check for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PF-07248144 and fluconazole
- What this could lead to
- If successful, this study could help determine the right dose of PF-07248144 when taken with fluconazole, improving safety and effectiveness in future trials.
- What could go wrong
- This is a very early, small study in healthy volunteers, not patients. It only looks at drug levels and safety, not whether PF-07248144 works for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pfizer Clinical Research Unit - Brussels
Brussels, Bruxelles-capitale, Région de, B-1070, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Breakfast or fast? a trial puts Prifetrastat's absorption to the test
- Magic mushroom compound may rewire Self-Awareness — scientists put it to the test
- Can a phone app ease caregiver burnout? new study tests digital therapy
- Robotic hip brace may help control blood sugar after eating
- Smart knee brace and AI could revolutionize home rehab for arthritis
- Training the brain to hear and fix speech errors